Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 29.3T | 28.0T | 27.1T | 26.5T |
Cost of revenue | 23.5T | 21.9T | 21.4T | 20.4T |
Gross profit | 5.9T | 6.1T | 5.7T | 6.1T |
Operating expense | ||||
Research & development | — | 454.8B | 505.5B | 395.0B |
Selling general and admin | 3.1T | 2.0T | 1.9T | 2.3T |
Other operating expenses | — | 37.0B | 42.9B | 37.4B |
Operating income | 5.9T | 3.0T | 2.7T | 2.9T |
Non operating interest income | ||||
Income | — | 257.2B | 267.6B | 261.0B |
Expense | — | 25.1B | 23.0B | 23.9B |
Other income expense | — | — | — | — |
Pretax income | 3.0T | 3.2T | 2.4T | 3.2T |
Tax provision | 732.0B | 850.8B | 702.4B | 963.9B |
Net income | 2.3T | 2.4T | 1.7T | 2.3T |
Basic EPS | 5.8K | 6.1K | — | 5.8K |
Diluted EPS | 5.8K | 6.1K | — | 5.8K |
Basic average shares | — | 393.7M | — | 391.8M |
Diluted average shares | — | 393.7M | — | 391.8M |
EBITDA | 5.9T | 3.9T | 3.4T | 3.9T |
Net income from continuing op. | — | 2.4T | 1.7T | 2.3T |
Minority interests | 624M | 373M | 480M | -243M |
Preferred stock dividends | — | — | — | — |